02/20/2026
NOW LIVE! Just presented at - We discuss the initial report of NRG-HN009 for advanced head & neck cancer in this podcast episode as well as the currently enrolling NRG-HN010 trial in HER2-expressing salivary gland cancer. Tune in: www.NRGOncology.org/Podcast